Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jean Francois Formela currently holds 14,677 shares of Intellia Therapeutics, Inc. (NTLA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jean Francois Formela has been a net seller of NTLA stock. They have purchased $17.3M and sold $239.8M worth of shares.
Jean Francois Formela's most recent insider trade was on Jun 10, 2026, when they sold 14,677 shares at $0.00 per share.
Jean Francois Formela serves as Executive at Intellia Therapeutics, Inc. (NTLA). They have executed 101 insider transactions totaling $257.1M over their tenure at the company.
Jean Francois Formela holds the position of Executive at Intellia Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Jean Francois Formela has shown a selling trading pattern, with $17.3M in total purchases and $239.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jean Francois Formela was on Sep 14, 2021, when they sold $78.1M worth of TBIO shares. This transaction involved 2,055,063 shares at $38.00 per share.
Jean Francois Formela currently owns 14,677 shares of Intellia Therapeutics, Inc. (NTLA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jean Francois Formela's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jean Francois Formela has 101 Form 4 filings on record as an insider at Intellia Therapeutics, Inc..
Set alerts for Jean Francois Formela and 40,000+ other insiders.